Clinical Trial

A Study of LY3549492 in Healthy Participants and Participants With Overweight or Obesity

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated May 22, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to see how safe and well-tolerated the drug LY3549492 is and how it behaves in the body, when given in multiple doses to healthy people who are overweight or have obesity. Participation in the study will last approximately 8 weeks.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-05-23
Trial Details
NCT Number NCT07232732
Lead Sponsor Eli Lilly and Company
Conditions Healthy, Obesity, Overweight
Enrollment 120 participants
Start Date 2025-10-27
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-05-22